Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)

Clinical trial NCT00168740 · COMPLETED

Trial details

NCT number: NCT00168740
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma

Start date: 1995-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.